Vic Gov launches Technology Voucher Program
Tuesday, 13 November, 2012
Growing on the success of the Victorian Government's “Small Technologies Industry Uptake Program” a new “Technology Voucher Program” (TVP) has been launched, offering vouchers in three categories:
- Technology Development vouchers valued at up to $50,000;
- Technology Implementation vouchers valued at up to $250,000; and
- Technology Student Accelerator vouchers valued at up to $10,000.
The TVP is primarily designed to support Victorian companies to use technologies – specifically ICT, industrial biotechnology and small technologies – in order to develop more competitive products, processes and services. As a secondary objective, the Program will also support non-Victorian companies to access Victorian technology know-how and services where there are significant and measurable benefits likely to flow to the State.
By supporting the adoption and integration of ICT, biotechnology and small technologies into business products and processes, the Program aims to facilitate improved performance (particularly with respect to productivity) and growth of businesses which are, or have the potential to become, high performing and internationally competitive.
The Program is primarily targeted at fast-growing small and medium sized enterprises. Large companies are also able to apply for vouchers for projects where there is substantial opportunity to capture benefits for the State.
Victorian small to medium size companies (1-199 employees) are eligible for a Technology Development Voucher, a Technology Implementation Voucher and a Technology Student Accelerator Voucher.
Large Victorian companies (200+ employees) are eligible for a Technology Development or a Technology Implementation Voucher.
Interstate companies are eligible for a Technology Development or a Technology Implementation Voucher.STC will administer, coordinate and facilitate the TVP application processes. See the STC website for the programs guidelines.
TGA rejects Alzheimer's drug due to safety concerns
The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did...
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...